PTGS2 and breast carcinoma: In soft agar and xenograft assays, the combined treatment of a PTGS2 (COX-2) selective inhibitor, an EGFR tyrosine kinase inhibitor, and a protein kinase A antisense construct markedly reduced proliferation and angiogenesis of human colon and breast cancer cells [92].